FOREVER INVESTED
At RocketBio, we invest in biotech – with a focus on tissue engineering and regenerative medicine companies – for the long term. We work side-by-side with founders to unlock sustainable growth and transformative breakthroughs.
Because we aim to hold our investments, we make every decision with a long-term view in mind.
The decisions you make when planning for the next fifty years are vastly different from those made with a five-year horizon. Nowhere is this more evident than in biotech, where the journey from lab to market can take years.
We partner closely with our portfolio companies to build mission-driven businesses that prioritize early customer engagement and drive meaningful impact for patients.
Our Areas of Focus
At RocketBio, our focus is on advancing Tissue Engineering and Regenerative Medicine, while remaining open to transformative opportunities across diagnostics and the broader biotech landscape. We believe that lasting innovation stems from a long-term vision—not from building companies for a quick flip. Similarly, we don’t confine ourselves to any one stage of investment. Whether partnering with a larger, established company or a younger, emerging venture, our commitment lies in being deeply involved in a strategic, enduring approach.
Regenerative Medicine
Regenerative medicine is a broad field focused on developing and applying new treatments to heal tissues and organs and restore function lost due to aging, disease, damage or defects. Techniques include stem cells, gene therapy, biomaterials and bioengineering.
Tissue Engineering
Tissue engineering is a multidisciplinary field that combines principles of biology, engineering, and materials science to develop biological substitutes , including models that help evaluate drug efficacy, toxicity, and disease progression more accurately, offering a more human-relevant platform for testing therapeutics and studying disease states.
rEADY TO GO?
Let’s Build The Future Together
